1. bookVolume 17 (2017): Edition 3 (December 2017)
Détails du magazine
License
Format
Magazine
eISSN
1338-4139
Première parution
03 Jun 2011
Périodicité
3 fois par an
Langues
Anglais
Accès libre

Potential Effect of Pharmacotherapy on Sympathetic Arousal in Autism

Publié en ligne: 20 Feb 2018
Volume & Edition: Volume 17 (2017) - Edition 3 (December 2017)
Pages: 16 - 23
Reçu: 18 Jan 2018
Accepté: 23 Jan 2018
Détails du magazine
License
Format
Magazine
eISSN
1338-4139
Première parution
03 Jun 2011
Périodicité
3 fois par an
Langues
Anglais

1) Benevides TW, Lane SJ. A review of cardiac autonomic measures: consideration for examination of physiological response in children with autism spectrum disorder. J Autism Dev Disord 2015; 45(2): 560–75.10.1007/s10803-013-1971-z24154761Search in Google Scholar

2) Leyfer OT, Folstein SE, Bacalman S, Davis NO, Dinh E, Morgan J et al. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord 2006; 36(7): 849-61.10.1007/s10803-006-0123-016845581Search in Google Scholar

3) Murray ML, Hsia Y, Glaser K, Simonoff E, Murphy DG, Asherson PJ et al. Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care. Psychopharmacology (Berl) 2014; 231(6): 1011-21.10.1007/s00213-013-3140-7393216723681164Search in Google Scholar

4) American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): American Psychiatric Publisher; 2013.10.1176/appi.books.9780890425596Search in Google Scholar

5) Mandell DS, Morales KH, Marcus SC, Stahmer AC, Doshi J, Polsky DE. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics 2008; 121(3): e441-8.10.1542/peds.2007-0984286143118310165Search in Google Scholar

6) Rosenberg RE, Mandell DS, Farmer JE, Law JK, Marvin AR, Law PA. Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008. J Autism Dev Disord 2010; 40(3): 342-51.10.1007/s10803-009-0878-119806445Search in Google Scholar

7) Ming X, Julu PO, Brimacombe M, Connor S, Daniels ML. Reduced cardiac parasympathetic activity in children with autism. Brain Dev 2005; 27(7): 509–16.10.1016/j.braindev.2005.01.00316198209Search in Google Scholar

8) Bal E, Harden E, Lamb D, Van Hecke AV, Denver JW, Porges SW. Emotion recognition in children with autism spectrum disorders: relations to eye gaze and autonomic state. J Autism Dev Disord 2010; 40(3): 358–70.10.1007/s10803-009-0884-319885725Search in Google Scholar

9) Kushki A, Drumm E, Pla Mobarak M, Tanel N, Dupuis A, Chau T et al. Investigating the autonomic nervous system response to anxiety in children with autism spectrum disorders. PLoS One 2013; 8(4): e59730.10.1371/journal.pone.0059730361832423577072Search in Google Scholar

10) Porges SW, Macellaio M, Stanfill SD, Mccue K, Lewis GF, Harden ER et al. Respiratory sinus arrhythmia and auditory processing in autism: modifiable deficits of an integrated social engagement system? Int J Psychophysiol 2013; 88(3): 261–70.10.1016/j.ijpsycho.2012.11.009361086323201146Search in Google Scholar

11) Patriquin MA, Scarpa A, Friedman BH, Porges SW. Respiratory sinus arrhythmia: a marker for positive social functioning and receptive language skills in children with autism spectrum disorders. Dev Psychobiol 2013; 55(2): 101–12.10.1002/dev.2100222212893Search in Google Scholar

12) Neuhaus E, Bernier R, Beauchaine TP. Brief report: social skills, internalizing and externalizing symptoms, and respiratory sinus arrhythmia in autism. J Autism Dev Disord 2014; 44(3): 730–7.10.1007/s10803-013-1923-723982488Search in Google Scholar

13) Anderson CJ, Colombo J, Unruh KE. Pupil and salivary indicators of autonomic dysfunction in autism spectrum disorder. Dev Psychobiol 2013; 55(5): 465-82.10.1002/dev.21051383214222644965Search in Google Scholar

14) Wagner JB, Luyster RJ, Tager-Flusberg H, Nelson CA. Greater pupil size in response to emotional faces as an early marker of social-communicative difficulties in infants at high risk for autism. Infancy 2016; 21(5): 560-81.10.1111/infa.12128501603427616938Search in Google Scholar

15) Kushki A, Brain J, Dupuis A, Anagnostou E. Functional autonomic nervous system profile in children with autism spectrum disorder. Mol Autism 2014; 5: 39.10.1186/2040-2392-5-39409949425031832Search in Google Scholar

16) Levine TP, Sheinkopf SJ, Pescosolido M, Rodino A, Elia G, Lester B. Physiologic arousal to social stress in children with autism spectrum disorders: a pilot study. Res Autism Spectr Disord 2012; 6(1): 177-83.10.1016/j.rasd.2011.04.003321239322081773Search in Google Scholar

17) Hollocks MJ, Howlin P, Papadopoulos AS, Khondoker M, Simonoff E. Differences in HPA-axis and heart rate responsiveness to psychosocial stress in children with autism spectrum disorders with and without co-morbid anxiety. Psychoneuroendocrinology 2014; 46: 32-45.10.1016/j.psyneuen.2014.04.00424882156Search in Google Scholar

18) Toichi M, Kamio Y. Paradoxical autonomic response to mental tasks in autism. J Autism Dev Disord 2003; 33(4): 417–26.10.1023/A:1025062812374Search in Google Scholar

19) Legiša J, Messinger DS, Kermol E, Marlier L. Emotional responses to odors in children with highfunctioning autism: autonomic arousal, facial behavior and self-report. J Autism Dev Disord 2013; 43(4): 869-79.10.1007/s10803-012-1629-2478497022918860Search in Google Scholar

20) O'Haire ME, McKenzie SJ, Beck AM, Slaughter V. Animals may act as social buffers: skin conductance arousal in children with autism spectrum disorder in a social context. Dev Psychobiol 2015; 57(5): 584–95.10.1002/dev.21310844790425913902Search in Google Scholar

21) Bujnakova I, Ondrejka I, Mestanik M, Visnovcova Z, Mestanikova A, Hrtanek I et al. Autism spectrum disorder is associated with autonomic underarousal. Physiol Res 2016; 65(Suppl 5): S673-S682.10.33549/physiolres.93352828006949Search in Google Scholar

22) Panju S, Brian J, Dupuis A, Anagnostou E, Kushki A. Atypical sympathetic arousal in children with autism spectrum disorder and its association with anxiety symptomatology. Mol Autism 2015; 6:64.10.1186/s13229-015-0057-5467688526693000Search in Google Scholar

23) Bink M, Popma A, Bongers IL, van Boxtel GJ, Denissen A, van Nieuwenhuizen Ch. Cardiac reactivity and stimulant use in adolescents with autism spectrum disorders with comorbid ADHD versus ADHD. J Autism Dev Disord 2015; 45(2): 481-94.10.1007/s10803-013-1929-124005985Search in Google Scholar

24) Daluwatte CH, Miles JH, Christ SE, Beversdorf DQ, Takahashi TN, Yao G. Atypical pupillary light reflex and heart rate variability in children with autism spectrum disorder. J Autism Dev Disord 2013; 43(8): 1910–25.10.1007/s10803-012-1741-3361902623248075Search in Google Scholar

25) Schoen SA, Miller LJ, Brett-Green B, Hepburn SL. Psychophysiology of children with autism spectrum disorder. Res Autism Spectr Disord 2008; 2(3): 417–29.10.1016/j.rasd.2007.09.002Search in Google Scholar

26) Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes 2012; 7(4): 284-94.10.1111/j.2047-6310.2012.00064.x22715120Search in Google Scholar

27) Ji N, Findling RL. An update on pharmacotherapy for autism spectrum disorder in children and adolescents. Curr Opin Psychiatry 2015; 28(2): 91-101.10.1097/YCO.000000000000013225602248Search in Google Scholar

28) Licht CM, Penninx BW, de Geus EJ. Effects of antidepressants, but not psychopathology, on cardiac sympathetic control: a longitudinal study. Neuropsychopharmacology 2012; 37(11): 2487-95.10.1038/npp.2012.107344234322763618Search in Google Scholar

29) Breitbart WS, Alici Y. Psychosocial palliative care. Oxford University Press; 2014.10.1093/med/9780199917402.003.0005Search in Google Scholar

30) Keks N, Hope J, Keogh S. Switching and stopping antidepressants. Australian Prescriber 2016; 39(3): 76-83.Search in Google Scholar

31) Dawson M, Schell A, Filion D. The electrodermal system. In: Cacioppo JT, Tassinary LG, Berntson GG, editors. Handbook of psychophysiology. New York: Cambridge University Press; 2000.Search in Google Scholar

32) Boucsein W. Electrodermal Activity. New York: Springer; 2012.10.1007/978-1-4614-1126-0Search in Google Scholar

33) Sequeira H, Hot P, Silvert L, Delplanque S. Electrical autonomic correlates of emotion. Int J Psychophysiol 2009; 71(1): 50–6.10.1016/j.ijpsycho.2008.07.009Search in Google Scholar

34) Brambilla P, Hardan A, di Nemi SU, Perez J, Soares JC, Barale F. Brain anatomy and development in autism: review of structural MRI studies. Brain Res Bull 2003; 61(6): 557-69.10.1016/j.brainresbull.2003.06.001Search in Google Scholar

35) Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends Neurosci 2008; 31(3): 137–45.10.1016/j.tins.2007.12.005Search in Google Scholar

36) Schumann CM, Barnes CC, Lord C, Courchesne E. Amygdala enlargement in toddlers with autism related to severity of social and communication impairments. Biol Psychiatry 2009; 66(10): 942–9.10.1016/j.biopsych.2009.07.007Search in Google Scholar

37) Stoner R, Chow ML, Boyle MP, Sunkin SM, Mouton PR, Roy S et al. Patches of disorganization in the neocortex of children with autism. N Engl J Med 2014; 370(13): 1209-19.10.1056/NEJMoa1307491Search in Google Scholar

38) Baron-Cohen S, Ring HA, Bullmore ET, Wheelwright S, Ashwin C, Williams SCR. The amygdala theory of autism. Neurosci Biobehav Rev 2000; 24(3): 355–64.10.1016/S0149-7634(00)00011-7Search in Google Scholar

39) Rausch A, Zhang W, Haak KV, Mennes M, Hermans EJ, van Oort E et al. Altered functional connectivity of the amygdaloid input nuclei in adolescents and young adults with autism spectrum disorder: a resting state fMRI study. Mol Autism 2016; 7: 13.10.1186/s13229-015-0060-x473062826823966Search in Google Scholar

40) Courchesne E, Pierce K. Why the frontal cortex in autism might be talking only to itself: local overconnectivity but long-distance disconnection. Curr Opin Neurobiol 2005; 15(2): 225-30.10.1016/j.conb.2005.03.00115831407Search in Google Scholar

41) Sikström S, Söderlund G. Stimulus-dependent dopamine release in attention-deficit/hyperactivity disorder. Psychol Rev 2007; 114(4): 1047–75.10.1037/0033-295X.114.4.104717907872Search in Google Scholar

42) Mukaddes NM, Hergüner S, Tanidir C: Psychiatric disorders in individuals with high-functioning autism and Asperger's disorder: similarities and differences. World J Biol Psychiatry 2010; 11(8): 964–71.10.3109/15622975.2010.50778520735157Search in Google Scholar

43) Murray MJ. Attention-deficit/hyperactivity disorder in the context of autism spectrum disorders. Curr Psychiatry Rep 2010; 12(5): 382-8.10.1007/s11920-010-0145-320694583Search in Google Scholar

44) Romero M, Aguilar JM, Del Rey-Mejías A, Mayoral F, Rapado M, Peciña M et al. Psychiatric comorbidities in autism spectrum disorder: A comparative study between DSM-IV-TR and DSM-5 diagnosis. Int J Clin Health Psychol 2016; 16(3): 266–75.10.1016/j.ijchp.2016.03.001622508830487870Search in Google Scholar

45) Lawrence CA, Barry RJ, Clarke AR, Johnstone SJ, Mccarthy R, Selikowitz M et al. Methylphenidate effects in attention deficit/hyperactivity disorder: electrodermal and ERP measures during a continuous performance task. Psychopharmacology (Berl) 2005; 183(1): 81-91.10.1007/s00213-005-0144-y16160877Search in Google Scholar

46) Awudu GA, Besag FM. Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an update. Drug Saf 2014; 37(9): 661-76.10.1007/s40264-014-0201-825124483Search in Google Scholar

47) Kasi PM, Mounzer R, Gleeson GH. Cardiovascular side effects of atomoxetine and its interactions with inhibitors of the cytochrome p450 system. Case Rep Med 2011; 2011: 952584.10.1155/2011/952584313522521765848Search in Google Scholar

48) Ding YS, Naganawa M, Gallezot JD, Nabulsi N, Lin SF, Ropchan J et al. Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD. Neuroimage 2014; 86: 164–71.10.1016/j.neuroimage.2013.08.00123933039Search in Google Scholar

49) Wernicke JF, Faries D, Girod D, Brown J, Gao H, Kelsey D et al. Cardiovascular effects of atomoxetine in children, adolescents, and adults. Drug Saf 2003; 26(10): 729-40.10.2165/00002018-200326100-0000612862507Search in Google Scholar

50) Garnock-Jones KP, Keating GM. Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatr Drugs 2009; 11(3): 203-26.10.2165/00148581-200911030-0000519445548Search in Google Scholar

51) Alvares GA, Quintana DS, Hickie IB, Guastella AJ. Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and metaanalysis. J Psychiatry Neurosci 2016; 41(2): 89-104.10.1503/jpn.140217476448526447819Search in Google Scholar

52) Tonhajzerova I, Ondrejka I, Adamik P, Hruby R, Javorka M, Trunkvalterova Z et al. Changes in the cardiac autonomic regulation in children with attention deficit hyperactivity disorder (ADHD). Indian J Med Res 2009; 130(1): 44-50.Search in Google Scholar

52) Tonhajzerova I, Farsky I, Mestanik M, Visnovcova Z, Mestanikova A, Hrtanek I et al. Symbolic dynamics of heart rate variability - a promising tool to investigate cardiac sympathovagal control in attention deficit/hyperactivity disorder (ADHD)? Can J Physiol Pharmacol 2016; 94(6): 579-87.10.1139/cjpp-2015-037526963175Search in Google Scholar

54) Griffiths KR, Quintana DS, Hermens DF, Spooner C, Tsang TW, Clarke S et al. Sustained attention and heart rate variability in children and adolescents with ADHD. Biol Psychol 2017; 124: 11-20.10.1016/j.biopsycho.2017.01.00428099875Search in Google Scholar

Articles recommandés par Trend MD

Planifiez votre conférence à distance avec Sciendo